Copyright © 2003 by the European Society of Cardiology.
Regular Articles
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts
a Institute of Epidemiology and Social Medicine, University Muenster, D 48129 Muenster, Germany
b Atherosclerosis Research Institute at the University Muenster, D 48129 Munster, Germany
c Institute of Epidemiology, GSF-National Research Center Neuherberg, D 85764 Oberschleissheim, Germany
* Corresponding author. Tel.: +49-251-835-5399; fax: +49-251-835-5300
E-mail address: hense{at}uni-muenster.de
Received 15 October 2002; revised 27 December 2002; accepted 14 January 2003
Background The prediction of the absolute risk of coronary heart disease (CHD) is commonly based on risk prediction equations that originate from the Framingham Heart Study. However, differences in population risk levels compromise the external validity of these risk functions.
Setting and study population Participants aged 35–64 years from the MONICA Augsburg (2861 men and 2925 women) and the PROCAM (5527 men and 3155 women) cohorts were followed-up with regard to incident non-fatal myocardial infarction (MI) and fatal coronary events. For each participant, the predicted absolute risk of fatal plus non-fatal events was derived using Framingham risk equations. Predicted and actually observed risks were compared.
Results The two cohorts were similar in their baseline characteristics. Coronary risk predicted by the Framingham risk function substantially exceeded the risk actually observed in the German cohorts, irrespective of gender. The difference between predicted and observed absolute CHD risk increased with age while the ratio of predicted over observed risk remained constant at about a value of 2. Taking potentials for underascertainment in the German cohorts due to unrecognised MI and sudden deaths into account, the residual magnitude of risk overestimation by the Framingham risk function is probably at least 50%.
Conclusions Local guidelines for the management of patients with risk factors need to correct for this overestimation to avoid inadequate initiation of treatment and inflation of costs in primary prevention. Similar studies should be conducted in other populations with the aim of defining appropriate factors that calibrate absolute risk predictions to local population levels of CHD risk.
Key Words: Coronary risk prediction • Prospective study • Primary prevention
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Ketola, T. Laatikainen, and E. Vartiainen Evaluating risk for cardiovascular diseases--vain or value? How do different cardiovascular risk scores act in real life Eur J Public Health, May 29, 2009; (2009) ckp070v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C K Chow, R Joshi, D S Celermajer, A Patel, and B C Neal Recalibration of a Framingham risk equation for a rural population in India J Epidemiol Community Health, May 1, 2009; 63(5): 379 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Simmons, S. Sharp, S. M. Boekholdt, L. A. Sargeant, K.-T. Khaw, N. J. Wareham, and S. J. Griffin Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer-Norfolk Cohort: Does Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart Disease Events? Arch Intern Med, June 9, 2008; 168(11): 1209 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Weiner, H. Tighiouart, E. F. Elsayed, J. L. Griffith, D. N. Salem, A. S. Levey, and M. J. Sarnak The Framingham Predictive Instrument in Chronic Kidney Disease J. Am. Coll. Cardiol., July 17, 2007; 50(3): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]
|
|
|
|
|
|
Asia Pacific Cohort Studies Collaboration Cardiovascular risk prediction tools for populations in Asia J Epidemiol Community Health, February 1, 2007; 61(2): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]
|
|
|
|
|
|
J. Marrugat, I. Subirana, E. Comin, C. Cabezas, J. Vila, R. Elosua, B.-H. Nam, R. Ramos, J. Sala, P. Solanas, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study J Epidemiol Community Health, January 1, 2007; 61(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Brindle, A Beswick, T Fahey, and S Ebrahim Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review Heart, December 1, 2006; 92(12): 1752 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Assmann Dyslipidaemia and global cardiovascular risk: clinical issues Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F40 - F46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Tunstall-Pedoe, M Woodward, and for the SIGN group on risk estimation By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease Heart, March 1, 2006; 92(3): 307 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fornasini, C. Brotons, J. Sellares, M. Martinez, M. L. Galan, I. Saenz, and J. Manuel da Pena Consequences of using different methods to assess cardiovascular risk in primary care Fam. Pract., February 1, 2006; 23(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ballantyne, B. Arroll, and J. Shepherd Lipids and CVD management: towards a global consensus Eur. Heart J., November 1, 2005; 26(21): 2224 - 2231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Assmann Calculating global risk: the key to intervention Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F9 - F14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ferrario, P. Chiodini, L. E Chambless, G. Cesana, D. Vanuzzo, S. Panico, R. Sega, L. Pilotto, L. Palmieri, S. Giampaoli, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation Int. J. Epidemiol., April 1, 2005; 34(2): 413 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Konrad, C. Langer, G.A. Muller, K. Berger, R. Dziewas, F. Stogbauer, D.G. Nabavi, R. Junker, E.B. Ringelstein, and G. Kuhlenbaumer Protease Inhibitors in Spontaneous Cervical Artery Dissections Stroke, January 1, 2005; 36(1): 9 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M Ridker, P. W.F. Wilson, and S. M. Grundy Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk? Circulation, June 15, 2004; 109(23): 2818 - 2825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, Y. Hong, R. B. D'Agostino Sr, Z. Wu, W. Wang, J. Sun, P. W. F. Wilson, W. B. Kannel, and D. Zhao Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared With the Chinese Multi-provincial Cohort Study JAMA, June 2, 2004; 291(21): 2591 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. von Eckardstein Is there a need for novel cardiovascular risk factors? Nephrol. Dial. Transplant., April 1, 2004; 19(4): 761 - 765. [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Hense Observations, predictions and decisions--assessing cardiovascular risk assessment Int. J. Epidemiol., April 1, 2004; 33(2): 235 - 239. [Full Text] [PDF]
|
|
|
|
|
|
J. Emberson, P. Whincup, R. Morris, M. Walker, and S. Ebrahim Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease Eur. Heart J., March 2, 2004; 25(6): 484 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. McKee Commentary: Winners and losers Int. J. Epidemiol., December 1, 2003; 32(6): 1087 - 1088. [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Hense Risk factor scoring for coronary heart disease BMJ, November 29, 2003; 327(7426): 1238 - 1239. [Full Text] [PDF]
|
|
|
|
|
|
J.P Empana, P Ducimetiere, D Arveiler, J Ferrieres, A Evans, J.B Ruidavets, B Haas, J Yarnell, A Bingham, P Amouyel, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations?: The PRIME Study Eur. Heart J., November 1, 2003; 24(21): 1903 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Muller-Nordhorn Population-based cardiovascular risk prediction Eur. Heart J., October 1, 2003; 24(19): 1796 - 1796. [Full Text] [PDF]
|
|
|
|
|
|
G. Assmann, P. Cullen, and H. Schulte Methods to identify increased risk of coronary disease in the general population: Conclusion is oversimplification BMJ, September 13, 2003; 327(7415): 619 - 619. [Full Text] [PDF]
|
|